{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:20:10Z","timestamp":1794612010272,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T00:00:00Z","timestamp":1541203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008397","name":"The Velux Foundations","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008397","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Danish Parkinson Association"},{"name":"The Grosserer Foghts Foundation"},{"name":"The Else and Ejner Danielsens Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1339-6","type":"journal-article","created":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T02:07:29Z","timestamp":1541210849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes"],"prefix":"10.1186","volume":"15","author":[{"given":"C.","family":"Starhof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Winge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. H. H.","family":"Heegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Skogstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Friis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hejl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,3]]},"reference":[{"key":"1339_CR1","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S. Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol. 2009;8:382\u201397.","journal-title":"Lancet Neurol"},{"key":"1339_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0733-8619(18)30215-9","volume":"10","author":"WR Gibb","year":"1992","unstructured":"Gibb WR. Neuropathology of Parkinson\u2019s disease and related syndromes. Neurol Clin. 1992;10:361\u201376.","journal-title":"Neurol Clin"},{"key":"1339_CR3","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology. 1988;38:1285\u201391.","journal-title":"Neurology"},{"key":"1339_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1440-1789.2007.00855.x","volume":"28","author":"K Ishizawa","year":"2008","unstructured":"Ishizawa K, Komori T, Arai N, Mizutani T, Hirose T. Glial cytoplasmic inclusions and tissue injury in multiple system atrophy: a quantitative study in white matter (olivopontocerebellar system) and gray matter (nigrostriatal system). Neuropathology. 2008;28:249\u201357.","journal-title":"Neuropathology"},{"key":"1339_CR5","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.parkreldis.2011.06.007","volume":"17","author":"R Fernandez-Botran","year":"2011","unstructured":"Fernandez-Botran R, Ahmed Z, Crespo FA, Gatenbee C, Gonzalez J, Dickson DW, Litvan I. Cytokine expression and microglial activation in progressive supranuclear palsy. Parkinsonism Relat Disord. 2011;17:683\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"1339_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","volume":"7","author":"ME Lull","year":"2010","unstructured":"Lull ME, Block ML. Microglial activation and chronic neurodegeneration. Neurotherapeutics. 2010;7:354\u201365.","journal-title":"Neurotherapeutics"},{"key":"1339_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","volume":"202","author":"D Blum-Degen","year":"1995","unstructured":"Blum-Degen D, Muller T, Kuhn W, Gerlach M, Przuntek H, Riederer P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease patients. Neurosci Lett. 1995;202:17\u201320.","journal-title":"Neurosci Lett"},{"key":"1339_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","volume":"165","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett. 1994;165:208\u201310.","journal-title":"Neurosci Lett"},{"key":"1339_CR9","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1309\/W01Y0B808EMEH12L","volume":"129","author":"J Zhang","year":"2008","unstructured":"Zhang J, Sokal I, Peskind ER, Quinn JF, Jankovic J, Kenney C, Chung KA, Millard SP, Nutt JG, Montine TJ. CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol. 2008;129:526\u20139.","journal-title":"Am J Clin Pathol"},{"key":"1339_CR10","doi-asserted-by":"publisher","first-page":"e0135458","DOI":"10.1371\/journal.pone.0135458","volume":"10","author":"M Wennstrom","year":"2015","unstructured":"Wennstrom M, Surova Y, Hall S, Nilsson C, Minthon L, Hansson O, Nielsen HM. The inflammatory marker YKL-40 is elevated in cerebrospinal fluid from patients with Alzheimer\u2019s but not Parkinson\u2019s disease or dementia with Lewy bodies. PLoS One. 2015;10:e0135458.","journal-title":"PLoS One"},{"key":"1339_CR11","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.clinbiochem.2013.12.024","volume":"47","author":"CE Teunissen","year":"2014","unstructured":"Teunissen CE, Tumani H, Engelborghs S, Mollenhauer B. Biobanking of CSF: international standardization to optimize biomarker development. Clin Biochem. 2014;47:288\u201392.","journal-title":"Clin Biochem"},{"key":"1339_CR12","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/mds.25327","volume":"28","author":"G Respondek","year":"2013","unstructured":"Respondek G, Roeber S, Kretzschmar H, Troakes C, Al-Sarraj S, Gelpi E, Gaig C, Chiu WZ, van Swieten JC, Oertel WH, H\u00f6glinger GU. Accuracy of the National Institute for Neurological Disorders and Stroke\/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy. Mov Disord. 2013;28:504\u20139.","journal-title":"Mov Disord"},{"issue":"9","key":"1339_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S. Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71(9):670\u2013676.","journal-title":"Neurology"},{"key":"1339_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1339_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1471-2407-4-94","volume":"4","author":"WH Hall","year":"2004","unstructured":"Hall WH, Ramachandran R, Narayan S, Jani AB, Vijayakumar S. An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer. 2004;4:94.","journal-title":"BMC Cancer"},{"key":"1339_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12311","volume":"42","author":"MG Spillantini","year":"2016","unstructured":"Spillantini MG, Goedert M. Synucleinopathies: past, present and future. Neuropathol Appl Neurobiol. 2016;42:3\u20135.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1339_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1\u20139.","journal-title":"Neurology"},{"key":"1339_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neuroscience.2014.11.018","volume":"302","author":"MS Moehle","year":"2015","unstructured":"Moehle MS, West AB. M1 and M2 immune activation in Parkinson\u2019s disease: foe and ally? Neuroscience. 2015;302:59\u201373.","journal-title":"Neuroscience"},{"key":"1339_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.pneurobio.2016.04.006","volume":"155","author":"V Joers","year":"2016","unstructured":"Joers V, Tansey MG, Mulas G, Carta AR. Microglial phenotypes in Parkinson\u2019s disease and animal models of the disease. Prog Neurobiol. 2016;155:57\u201375.","journal-title":"Prog Neurobiol"},{"key":"1339_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.brainres.2011.07.047","volume":"1414","author":"WM Juma","year":"2011","unstructured":"Juma WM, Lira A, Marzuk A, Marzuk Z, Hakim AM, Thompson CS. C-reactive protein expression in a rodent model of chronic cerebral hypoperfusion. Brain Res. 2011;1414:85\u201393.","journal-title":"Brain Res"},{"key":"1339_CR21","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/mds.27001","volume":"32","author":"M Delgado-Alvarado","year":"2017","unstructured":"Delgado-Alvarado M, Gago B, Gorostidi A, Jimenez-Urbieta H, Dacosta-Aguayo R, Navalpotro-Gomez I, Ruiz-Martinez J, Bergareche A, Marti-Masso JF, Martinez-Lage P, et al. Tau\/alpha-synuclein ratio and inflammatory proteins in Parkinson\u2019s disease: an exploratory study. Mov Disord. 2017;32:1066\u201373.","journal-title":"Mov Disord"},{"key":"1339_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbi.2013.07.007","volume":"33","author":"D Lindqvist","year":"2013","unstructured":"Lindqvist D, Hall S, Surova Y, Nielsen HM, Janelidze S, Brundin L, Hansson O. Cerebrospinal fluid inflammatory markers in Parkinson\u2019s disease--associations with depression, fatigue, and cognitive impairment. Brain Behav Immun. 2013;33:183\u20139.","journal-title":"Brain Behav Immun"},{"key":"1339_CR23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/sj.embor.7400922","volume":"8","author":"G Pawelec","year":"2007","unstructured":"Pawelec G. Immunosenescence comes of age. Symposium on aging research in immunology: the impact of genomics. EMBO Rep. 2007;8:220\u20133.","journal-title":"EMBO Rep"},{"key":"1339_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2217\/bmm.12.46","volume":"6","author":"M del Campo","year":"2012","unstructured":"del Campo M, Mollenhauer B, Bertolotto A, Engelborghs S, Hampel H, Simonsen AH, Kapaki E, Kruse N, Le Bastard N, Lehmann S, et al. Recommendations to standardize preanalytical confounding factors in Alzheimer\u2019s and Parkinson\u2019s disease cerebrospinal fluid biomarkers: an update. Biomark Med. 2012;6:419\u201330.","journal-title":"Biomark Med"},{"key":"1339_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2217\/bmm.13.125","volume":"8","author":"L Salvesen","year":"2014","unstructured":"Salvesen L, Tanassi JT, Bech S, Palhagen S, Svenningsson P, Heegaard NH, Winge K. The influence of preanalytical conditions on the DJ-1 concentration in human cerebrospinal fluid. Biomark Med. 2014;8:387\u201394.","journal-title":"Biomark Med"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1339-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1339-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1339-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T06:20:21Z","timestamp":1589955621000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1339-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1339"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1339-6","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,3]]},"assertion":[{"value":"15 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Local Ethics Committee (jr.no. H-3-2013-191) and the Danish Data Protection Agency (jr.no. 2007-58-0015; BBH-2014-002). All patients provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"305"}}